As of Jul 29
| -0.12 / -1.42%|
The 3 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 11.00. The median estimate represents a +43.71% increase from the last price of 8.35.
The current consensus among 3 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.